The ROE as of December 2024 (TTM) for Novan, Inc. (NOVN) is -170.66%

According to Novan, Inc.’s latest financial reports and current stock price. The company's current ROE is -170.66%. This represents a change of -170.62% compared to the average of 241.66% of the last 4 quarters.

Novan, Inc. (NOVN) Historical ROE (quarterly & annually)

How has NOVN ROE performed in the past?

The mean historical ROE of Novan, Inc. over the last ten years is -14.58%. The current -170.66% ROE has changed 1.07% with respect to the historical average. Over the past ten years (40 quarters), NOVN's ROE was at its highest in in the June 2020 quarter at 21.85%. The ROE was at its lowest in in the March 2021 quarter at -1053.18%.

Novan, Inc. (NOVN) ROE by Quarter and Year

Discovering the peaks and valleys of Novan, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Novan, Inc. (NOVN) Average ROE

How has NOVN ROE performed in the past?

The current ROE of Novan, Inc. (NOVN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Novan, Inc. (NOVN) ROE vs. Peers

How is NOVN’s ROE compared to its peers?

Novan, Inc.’s ROE is greater than Tarsus Pharmaceuticals, Inc. (-55.86%), greater than LianBio (-21.53%), greater than Aldeyra Therapeutics, Inc. (-43.01%), greater than Travere Therapeutics, Inc. (-541.59%), greater than Eton Pharmaceuticals, Inc. (-36.29%), greater than Tonix Pharmaceuticals Holding Corp. (-163.95%), greater than Jaguar Health, Inc. (-287.85%), greater than Acasti Pharma Inc. (-18.84%), greater than Diffusion Pharmaceuticals Inc. (-44.12%), greater than iBio, Inc. (-126.61%), greater than Aditxt, Inc. (-431.38%), greater than Palisade Bio, Inc. (-148.31%), less than Plus Therapeutics, Inc. (271.49%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), less than Onconova Therapeutics, Inc. (619.75%), greater than Adial Pharmaceuticals, Inc. (-256.25%), greater than Aeterna Zentaris Inc. (-84.15%), greater than Lyra Therapeutics, Inc. (-178.68%), greater than Trevi Therapeutics, Inc. (-63.30%), greater than SQZ Biotechnologies Company (-305.92%), greater than Protara Therapeutics, Inc. (-55.96%), greater than TRACON Pharmaceuticals, Inc. (-237.65%),

Build a custom stock screener for Novan, Inc. (NOVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novan, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novan, Inc. (NOVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novan, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.